Johnson Pledges Review of U.K.’s ‘Sin Taxes’ on Salt, Fat, Sugar
(Bloomberg) -- Boris Johnson, the favorite to replace Theresa May as U.K. prime minister, has pledged he'll launch a review of “sin taxes” on salt, fat and sugar, a signal that he wants to adopt an economically liberal approach after years in which government tried to clamp down on unhealthy behavior.
Johnson said in a press release he wanted to be convinced that such taxes worked, and that they didn't hit the poorest hardest. “The recent proposal for a tax on milkshakes seems to me to clobber those who can least afford it,” he said. “If we want people to lose weight and live healthier lifestyles, we should encourage people to walk, cycle and generally do more exercise.”
The announcement may cause some discomfort to Health Secretary Matt Hancock, who has become a leading backer of Johnson. Last week, according to two people familiar with the matter, Hancock's department circulated a policy paper, due to be published next week, proposing extending the existing sugar tax to milkshakes and a ban on the sale of energy drinks to children.
The Department of Health said in a statement that its policies “have always been guided by evidence and will continue to be in the future.” But Johnson's announcement means it's unlikely either anti-sugar proposal will be picked up if Johnson wins power.
To contact the reporter on this story: Robert Hutton in London at rhutton1@bloomberg.net
To contact the editors responsible for this story: Tim Ross at tross54@bloomberg.net, Robert Jameson
©2019 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.